Published in Gene Therapy Weekly, March 9th, 2000
"Thrombopoietin (TPO) is likely to be a potent, specific, and reliable medication in the treatment of thrombocytopenia," stated S. Chong and colleagues, Fudan University, China. "A TPO-highly-expressed plasmid pcDNA3-TPO was constructed and a primary study was made on the expression of TPO cDNA in vitro and gene transfer study for thrombocytopenia in vivo."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly